Showing results (1-10 of 1,231) with videos related to
Sort By:
Pageof 124
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Oxaliplatin and axonal Na+ channel function in vivoArun V Krishnan, David Goldstein, Michael Friedlander, et al.Muscle & Nerve|May 10, 2005
Oxaliplatin-induced neurotoxicity and the development of neuropathyArun V Krishnan, David Goldstein, Michael Friedlander, et al.Brain : a Journal of Neurology|March 11, 2005
Altered nerve excitability properties in established diabetic neuropathyArun V Krishnan, Matthew C KiernanCurrent Medicinal Chemistry|November 1, 2006
The pathophysiology of oxaliplatin-induced neurotoxicityMatthew C Kiernan, Arun V KrishnanMuscle & Nerve|February 3, 2006
Axonal function and activity-dependent excitability changes in myotonic dystrophyArun V Krishnan, Matthew C KiernanMultiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2012
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosisArun V Krishnan, Matthew C KiernanMuscle & Nerve|December 30, 2006
Uremic neuropathy: clinical features and new pathophysiological insightsArun V Krishnan, Matthew C KiernanNature Reviews. Neurology|September 3, 2009
Neurological complications of chronic kidney diseaseArun V Krishnan, Matthew C KiernanSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2020
Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy-a randomised controlled trialTerry Trinh, Susanna B Park, Jenna Murray, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2007
Axonal excitability properties in hemifacial spasmArun V Krishnan, Michael Hayes, Matthew C KiernanPageof 124